2/17/2009

Mayo Clinic researchers reported Crohn's patients who no longer respond to infliximab may get results from induction therapy with certolizumab pegol. Results of the 26-week trial showed 62% of 539 patients not responding to infliximab had clinical responses to certolizumab pegol.

Full Story:
Doctor's Guide

Related Summaries